CSL Limited (ASX: CSL)
Australia
· Delayed Price · Currency is AUD 271.57
-1.85 (-0.68%)
Jan 22, 2025, 10:40 AM AEST
CSL Limited Employees
CSL Limited had 32,698 employees as of June 30, 2024. The number of employees increased by 633 or 1.97% compared to the previous year.
Employees
32,698
Change (1Y)
633
Growth (1Y)
1.97%
Revenue / Employee
678.40K AUD
Profits / Employee
121.10K AUD
Market Cap
132.39B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pro Medicus | 69 |
| Cochlear | 5,097 |
| Sonic Healthcare | 42,000 |
| Telix Pharmaceuticals | 234 |
| Ramsay Health Care | 90,000 |
| Ansell | 15,000 |
| Mesoblast | 73 |
| Regis Healthcare | 11,000 |
CSL Limited News
- 5 weeks ago - CSL Receives Positive CHMP Opinion for Garadacimab in Hereditary Angioedema (HAE) - PRNewsWire
- 3 months ago - New Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal Influenza - PRNewsWire
- 3 months ago - CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy - PRNewsWire
- 3 months ago - CSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza Vaccines - PRNewsWire
- 3 months ago - GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report - Benzinga
- 3 months ago - CSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian Influenza - PRNewsWire
- 3 months ago - Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply - BNN Bloomberg
- 4 months ago - CSL Seqirus Presents Real-World Evidence at OPTIONS XII Conference Highlighting Effectiveness of Influenza Vaccinations - PRNewsWire